BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukherjee S, Madamsetty VS, Bhattacharya D, Roy Chowdhury S, Paul MK, Mukherjee A. Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Adv Funct Mater 2020;30:2003054. [DOI: 10.1002/adfm.202003054] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh S, Hema, Sharma N, Sachdeva M, Behl T, Zahoor I, Fuloria NK, Sekar M, Fuloria S, Subramaniyan V, Alsubayiel AM, Dailah HG, Naved T, Bhatia S, Al-harrasi A, Aleya L. Focusing the pivotal role of nanotechnology in Huntington’s disease: an insight into the recent advancements. Environ Sci Pollut Res. [DOI: 10.1007/s11356-022-22830-2] [Reference Citation Analysis]
2 Zhang L, Liu Y, Huang H, Xie H, Zhang B, Xia W, Guo B. Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors. Adv Drug Deliv Rev 2022;190:114536. [PMID: 36108792 DOI: 10.1016/j.addr.2022.114536] [Reference Citation Analysis]
3 La Barbera L, Mauri E, D’amelio M, Gori M. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Front Neurosci 2022;16:939855. [DOI: 10.3389/fnins.2022.939855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gad HA, Mansour M, Abbas H, Malatani RT, Khattab MA, Elmowafy E. “Plurol will not miss the boat”: A new manifesto of galantamine conveyance. Journal of Drug Delivery Science and Technology 2022;74:103516. [DOI: 10.1016/j.jddst.2022.103516] [Reference Citation Analysis]
5 Ouyang J, Rao S, Liu R, Wang L, Chen W, Tao W, Kong N. 2D materials-based nanomedicine: From discovery to applications. Adv Drug Deliv Rev 2022;185:114268. [PMID: 35398466 DOI: 10.1016/j.addr.2022.114268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
6 Ouyang J, Xie A, Zhou J, Liu R, Wang L, Liu H, Kong N, Tao W. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging. Chem Soc Rev 2022. [PMID: 35616098 DOI: 10.1039/d1cs01148k] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
7 He X, Xie J, Zhang J, Wang X, Jia X, Yin H, Qiu Z, Yang Z, Chen J, Ji Z, Yu W, Chen M, Xu W, Gao H. Acid-Responsive Dual-Targeted Nanoparticles Encapsulated Aspirin Rescue the Immune Activation and Phenotype in Autism Spectrum Disorder. Adv Sci (Weinh) 2022;9:e2104286. [PMID: 35285177 DOI: 10.1002/advs.202104286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhu C, Yang Y, Li X, Chen X, Lin X, Wu X. Develop potential multi-target drugs by self-assembly of quercetin with amino acids and metal ion to achieve significant efficacy in anti-Alzheimer’s disease. Nano Res . [DOI: 10.1007/s12274-021-4066-8] [Reference Citation Analysis]
9 Zare I, Yaraki MT, Speranza G, Najafabadi AH, Haghighi AS, Nik AB, Manshian BB, Saraiva C, Soenen SJ, Kogan MJ, Lee JW, Apollo NV, Bernardino L, Araya E, Mayer D, Mao G, Hamblin MR. Gold nanostructures: synthesis, properties, and neurological applications. Chem Soc Rev 2022. [PMID: 35234776 DOI: 10.1039/d1cs01111a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Phuna ZX, Panda BP, Shivashekaregowda NKH, Madhavan P. Recent development in nanocrystal based drug delivery for neurodegenerative diseases: Scope, challenges, current and future prospects. Journal of Drug Delivery Science and Technology 2022;68:102921. [DOI: 10.1016/j.jddst.2021.102921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fakhri S, Abdian S, Zarneshan SN, Moradi SZ, Farzaei MH, Abdollahi M. Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases. IJN 2022;Volume 17:299-331. [DOI: 10.2147/ijn.s347187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Morse SV, Mishra A, Chan TG, T M de Rosales R, Choi JJ. Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles. J Control Release 2021;341:605-15. [PMID: 34896448 DOI: 10.1016/j.jconrel.2021.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Mayorga‐burrezo P, Mayorga‐martinez CC, Pumera M. Light‐Driven Micromotors to Dissociate Protein Aggregates That Cause Neurodegenerative Diseases. Adv Funct Materials 2022;32:2106699. [DOI: 10.1002/adfm.202106699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Lee JH, Rim YS, Min WK, Park K, Kim HT, Hwang G, Song J, Kim HJ. Biocompatible and Biodegradable Neuromorphic Device Based on Hyaluronic Acid for Implantable Bioelectronics. Adv Funct Mater 2021;31:2107074. [DOI: 10.1002/adfm.202107074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang L, Sun H, Zhao J, Lee J, Ee Low L, Gong L, Chen Y, Wang N, Zhu C, Lin P, Liang Z, Wei M, Ling D, Li F. Dynamic nanoassemblies for imaging and therapy of neurological disorders. Adv Drug Deliv Rev 2021;175:113832. [PMID: 34146626 DOI: 10.1016/j.addr.2021.113832] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Peng F, Jeong S, Ho A, Evans CL. Recent progress in plasmonic nanoparticle-based biomarker detection and cytometry for the study of central nervous system disorders. Cytometry A 2021. [PMID: 34328262 DOI: 10.1002/cyto.a.24489] [Reference Citation Analysis]
18 Xie X, Tang J, Xing Y, Wang Z, Ding T, Zhang J, Cai K. Intervention of Polydopamine Assembly and Adhesion on Nanoscale Interfaces: State-of-the-Art Designs and Biomedical Applications. Adv Healthc Mater 2021;10:e2002138. [PMID: 33690982 DOI: 10.1002/adhm.202002138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
19 Liu W, Dong X, Liu Y, Sun Y. Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review. Acta Biomater 2021;123:93-109. [PMID: 33465508 DOI: 10.1016/j.actbio.2021.01.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Moorthy H, Govindaraju T. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Appl Bio Mater 2021;4:1115-39. [PMID: 35014470 DOI: 10.1021/acsabm.0c01319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
21 Zhang L, Sun H, Chen Y, Wei M, Lee J, Li F, Ling D. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1696. [PMID: 33463089 DOI: 10.1002/wnan.1696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang X, Zhou J, Gu Z, Zhang H, Gong Q, Luo K. Advances in nanomedicines for diagnosis of central nervous system disorders. Biomaterials 2021;269:120492. [PMID: 33153757 DOI: 10.1016/j.biomaterials.2020.120492] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]